The workshop was organized by Vietnam Japan International Joint Stock Company (JVI) in collaboration with Vietnam Exhibition and Advertising Joint Stock Company (VIETFAIR) and the Vietnam-Japan Medical Exchange Association (VJME) on the morning of 6/5 at the Viet Xo Friendship Cultural Palace in Hanoi.

This significant medical event took place within the framework of the 34th Vietnam Medi Pharm International Medical and Pharmaceutical Exhibition (Vietnam Medi Pharm 2026), attracting over 280 guests and medical professionals from both Vietnam and abroad.

Japanese and Vietnamese experts discuss at the workshop. *Photo: Manh Tran*

This year's event saw participation from experts representing major Japanese hospitals and preventive medicine units, including: Ariake Cancer Institute Hospital, CVI Cardiovascular Research Institute Hospital, and Helene Stem Cell Center.

These international experts offered profound insights, providing opportunities to explore advanced healthcare models effectively implemented in Japan.

Associate Professor, Doctor Hiromichi Ito from Ariake Cancer Institute Hospital presents on the diagnosis and treatment of hepatocellular carcinoma at the workshop. *Photo: Manh Tran*

Doctor Dinh Ngoc Hai, Chairman of the Vietnam-Japan Medical Exchange Association (VJME), highlighted that the workshop delivered in-depth perspectives and direct updates from leading Japanese experts. This initiative opens doors for accessing advanced healthcare models successfully applied in Japan.

Beyond sharing specialized knowledge, the event also served as a platform for medical organizations, businesses, and the community to connect and exchange experiences in implementing advanced preventive medicine models. Through this collaboration, Japanese solutions can be studied and adapted for suitable application in Vietnam, contributing to improved healthcare quality for the population.

Doctor Dinh Ngoc Hai, VJME Chairman (center), and Mr. Takaaki Matsuoka (left), General Director of Helene Stem Cell Center Japan, at the workshop. *Photo: Manh Tran*

According to experts, the workshop was timely given the increasing prevalence and younger onset of dangerous chronic diseases like cancer and cardiovascular conditions. The global healthcare system is undergoing a clear shift from treatment to proactive prevention. Early detection is crucial not only for enhancing treatment effectiveness but also for extending healthy lifespans and reducing the long-term burden of illness.

Mr. Noda Mikihiro from CVI Cardiovascular Research Institute Japan addresses questions at the workshop. *Photo: Manh Tran*

Vietnam Japan International Joint Stock Company (JVI) is a provider of high-end Japanese medical services and a facilitator of advanced Japanese medical technology transfer in Vietnam. The company offers quality services and products including: stem cell therapy, immune therapy, medical examination and treatment in Japan, Japanese medical visas, and the transfer of Japanese medical technology to Vietnam.

After 10 years of establishment and development, JVI is a partner to many Japanese medical facilities and the representative of Helene Stem Cell Center in Vietnam.

Yen Chi

Contact information: 12th floor, ICON4 building, 243A De La Thanh, Lang ward, Hanoi.

Hotline: 0964 361 313 / 0984 361 313